Everpar Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Buy |
517
+71
| +16% | +$37.3K | 0.12% | 213 |
|
|
2025
Q1 | $283K | Sell |
446
-34
| -7% | -$21.6K | 0.15% | 193 |
|
|
2024
Q4 | $342K | Sell |
480
-113
| -19% | -$80.5K | 0.17% | 165 |
|
|
2024
Q3 | $623K | Sell |
593
-229
| -28% | -$241K | 0.32% | 78 |
|
|
2024
Q2 | $864K | Buy |
822
+133
| +19% | +$140K | 0.43% | 51 |
|
|
2024
Q1 | $663K | Sell |
689
-201
| -23% | -$193K | 0.4% | 71 |
|
|
2023
Q4 | $782K | Buy |
+890
| New | +$782K | 0.36% | 97 |
|